Also categorized in Specialties - OB/GYN and Women's Health:
The Next Big Thing in Birth Control: Amphora Offers Women a Missing Option
x hide permanently

Progenity to Present Key Prospective Verification Study Data for Its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians & Gynecologists Annual Meeting

Send Press Releases with GlobeNewswire

globenewswire.com

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products in women’s health, will be presenting verification study data for its Preecludia rule-out test for preeclampsia at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting set to take place April 30 – May 2, 2021.

The data presented will be a part of the virtual meeting’s interactive ePosters. Details of the presentation are as follows:

Title – Performance of a novel multi-biomarker rule out preeclampsia test: a prospective verification study
Authors – Matthew Cooper, Ph.D ...